ELEVATED LEVELS OF SUBSTANCE-P IN INTRAOCULAR FLUID IN PROLIFERATIVE VITREORETINOPATHY

被引:10
作者
KIESELBACH, GF
WIEDERMANN, C
KUNZE, C
GOTTINGER, W
HUMPEL, C
SARIA, A
机构
[1] UNIV INNSBRUCK,DEPT INTERNAL MED,A-6020 INNSBRUCK,AUSTRIA
[2] UNIV INNSBRUCK,DEPT PSYCHIAT,NEUROCHEM UNIT,A-6020 INNSBRUCK,AUSTRIA
关键词
PROLIFERATIVE VITREORETINOPATHY; SUBSTANCE-P; INTRAOCULAR FLUID; HUMAN EYE;
D O I
10.1016/0196-9781(91)90011-D
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Proliferative vitreoretinopathy is the most common reason for failure in retinal reattachment surgery. Since both substance P (SP) and SP receptors were found to be present in the human eye, and as pharmacological studies suggest an importance of SP for ocular functions, we investigated intraocular fluids for the presence of SP in eyes elected for cataract surgery, retinal detachment surgery and retina surgery for severe proliferative vitreoretinopathy (PVR) as well as in eyes with proliferative diabetic retinopathy (PDR). High performance liquid chromatography and radioimmunoassay (RIA) for SP immunoreactivities were performed. The SP mean concentration in intraocular fluid (IOF) of patients for cataract surgery (CS) was 2.2 fmol/ml, for retinal detachment (RD) was 2.7 fmol/ml and for PDR was 1.9 fmol/ml; significantly higher levels (mean concentration of 26.9 fmol/ml) were measured in eyes with PVR. HPLC analysis revealed two immunoreactive peaks coeluting with synthetic SP and SP-sulfoxide, indicating that RIA values represent authentic SP. We conclude that SP may play an important role in PVR. Since SP antagonists are known to inhibit a variety of SP effects in the eye, there might be a useful tool to reveal the importance of SP in this disease and, in this instance, a new possible treatment.
引用
收藏
页码:275 / 278
页数:4
相关论文
共 28 条
[1]   SUBSTANCE-P, NEUROKININ-A AND NEUROKININ-B IN THE OCULAR RESPONSE TO INJURY IN THE RABBIT [J].
BEDINGBARNEKOW, B ;
BRODIN, E ;
HAKANSON, R .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 95 (01) :259-267
[2]  
BURKE JM, 1989, PROLIFERATIVE VITREO, P80
[3]  
CAMPOCHIARO PA, 1985, ARCH OPHTHALMOL-CHIC, V103, P1403
[4]  
CAMPOCHIARO PA, 1981, INVEST OPHTHALMOL S, V20, P236
[5]  
DANIEL T, 1986, J BIOCH, V21, P9579
[6]  
FIJWARA M, 1984, J PHYSL, V350, P583
[7]   BLOCKADE OF SENSORY NERVE MEDIATED CONTRACTION OF THE RABBIT IRIS SPHINCTER BY A SERIES OF NOVEL TACHYKININ ANTAGONISTS [J].
HAKANSON, R ;
BEDING, B ;
LJUNGQVIST, A ;
CHU, JY ;
LEANDER, S ;
TROJNAR, J ;
FOLKERS, K .
REGULATORY PEPTIDES, 1988, 20 (02) :99-105
[8]   THE CLASSIFICATION OF RETINAL-DETACHMENT WITH PROLIFERATIVE VITREORETINOPATHY [J].
HILTON, G .
OPHTHALMOLOGY, 1983, 90 (02) :121-125
[9]   A SUBSTANCE-P ANTAGONIST, [D-PRO2, D-TRP7,9]SP, INHIBITS INFLAMMATORY RESPONSES IN THE RABBIT EYE [J].
HOLMDAHL, G ;
HAKANSON, R ;
LEANDER, S ;
ROSELL, S ;
FOLKERS, K ;
SUNDLER, F .
SCIENCE, 1981, 214 (4524) :1029-1031